The Nobel Prize in Chemistry: past, present, and future of AI in biology
Level 5 - mechanism / opinion, no new human data
Narrative commentary and perspective piece with no original empirical data (design analogy).
OpenAlex W4403873163 · doi:10.1038/s42003-024-07113-5
What was done
The author presented a narrative commentary examining the historical development, current status, and projected trajectory of artificial intelligence in structural biology. The overview focuses on the evolution of protein structure prediction through the Critical Assessment of Structure Prediction (CASP) experiments, de novo protein design, and the milestone achievements recognized by the 2024 Nobel Prize in Chemistry.
What was found
The abstract reports no quantitative data or empirical findings. It qualitatively outlines the progression from foundational structural prediction frameworks to de novo design capabilities and discusses potential future pathways toward AI models that model biological systems holistically.
Why it matters
This piece contextualizes how computational tools for protein structure prediction and design transformed molecular biology, culminating in the 2024 Nobel Prize in Chemistry. It frames current computational breakthroughs as building blocks toward holistic in silico biological modeling.
Limits
This is an expert commentary and perspective piece containing no original experimental data, trial results, or quantitative evidence synthesis. It represents theoretical overview and opinion rather than empirical research.
Cited by
- supports John Jumper and Demis Hassabis were awarded the Nobel Prize for developing AlphaFold to predict protein structure from sequence data.